Navigation Links
Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
Date:4/28/2008

NANJING, China, April 28 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced its participation in Credit Suisse's 3rd Annual Healthcare Trip, to be held May 6-10 and May 19-25 in Shenzhen, Shanghai, Beijing and Weihai.

Simcere senior management will give a presentation at the Grand Hyatt Shanghai on Wednesday, May 7, 2008, from 10:10 a.m. to 11:10 a.m. Beijing/Hong Kong time.

A copy of Simcere's investor presentation will be available on the investor relations portion of the Company's Web site, located at http://www.simcere.com.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has focused its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introduced a first-to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke management medication, and is the exclusive distributor of
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
2. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
3. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... PROVIDENCE, R.I. (Brown University) -- The discovery 30 years ... spur an explosion of nanotechnology research. Now, there appears ... Researchers from Brown University, Shanxi University and Tsinghua University ... boron atoms forms a hollow molecular cage similar to ... a boron cage structurepreviously only a matter of speculationdoes ...
(Date:7/13/2014)... 2014 2014 Deep Research Report on ... and in-depth study on the current state of the ... report provides a basic overview of the industry, including ... and Chinese domestic market analysis are provided with a ... the market. A comparison between the international and Chinese ...
(Date:7/12/2014)... York (PRWEB) July 12, 2014 ... for various reagents used in the life ... driving the life science reagents market towards ... include manufacturers and providers of life science ... Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . , The ...
(Date:7/11/2014)... July 11, 2014 /PRNewswire-iReach/ -- Maxim Peptide, a website ... are used solely in scientific experiments, is currently celebrating ... in business, Maxim Peptide, which was created by the ... new and updated website that now features a special ... been updated with fascinating articles about peptide research, including ...
Breaking Biology Technology:Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2
... Jan. 25 Today, the Board of Directors of ... Oncology, Inc.,(collectively, "US Oncology" or the "Company") announced that, ... his role as Chief,Executive Officer (CEO) and will continue ... Bruce D. Broussard will become the Company,s,President and CEO. ...
... PORT WASHINGTON, N.Y., Jan. 25 National,Medical Health Card ... benefit manager (PBM), announced today that it will host ... Eastern time, to,discuss its results for the 2008 fiscal ... press release after the market closes,on Thursday, February 7th., ...
... tech talent and investors to state, TOPEKA, ... (KTEC) announced today a "Come Home to Kansas" ... professionals,and investors to Kansas. Partners in this project ... Authority, the Kansas,Bioscience Organization and the KTEC PIPELINE., ...
Cached Biology Technology:US Oncology Announces Realignment of Executive Team 2US Oncology Announces Realignment of Executive Team 3NMHC to Host Fiscal Second Quarter 2008 Conference Call 2'Come Home to Kansas' Announced by KTEC 2
(Date:7/13/2014)... of more effective treatments for cachexia, a profound wasting ... all cancer patients, raising their risk of death, according ... have been tried to reverse the condition, which may ... treatments, but none have had great success. , Scientists ... Nature , led by Bruce Spiegelman, PhD, demonstrated ...
(Date:7/11/2014)... new report from the Wildlife Conservation Society shows ... help economically valuable species such as lobster, conch, ... help re-colonize nearby reef areas. , The reporttitled ... systematic review of research literature from no-take areas ... Dr. Craig Dahlgren, a recognized expert in marine ...
(Date:7/11/2014)... 11, 2014--Researchers at the Department of Energy,s Oak ... awards, presented by R&D Magazine in recognition of ... awards recognize the tremendous value of our National ... and development at the National Labs continues to ... pursue the scientific and technological innovations necessary to ...
Breaking Biology News(10 mins):Antibody halts cancer-related wasting condition 2Antibody halts cancer-related wasting condition 3Belize's lobster, conch, and fish populations rebuild in no-take zones 2ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4
... turned to the simple sponge to find clues about the ... for a mechanism that coordinates the expression of genes that ... rest of the animal world may not be so distant ... expression network," are published in the Proceedings of the ...
... will descend on Virginia Tech beginning June 24 bringing with ... economic boost to the Blacksburg area in excess of $2 ... of the largest conferences ever held in Blacksburg with 13 ... large molecules macromolecules that are having a huge ...
... rocks in Utah with iron-oxide rinds and fossilized bacteria ... rock material, plus noted similarities to "bacterial meal" ingredients ... volcanic hazards and warning systems for both high population ... most remote population on Earth; news from SAFOD; and ...
Cached Biology News:Clues to nervous system evolution found in nerve-less sponge 2Scientific meeting at Virginia Tech will make more than $2 million economic impact 2Scientific meeting at Virginia Tech will make more than $2 million economic impact 3Understanding faults and volcanics, plus life inside a rock 2Understanding faults and volcanics, plus life inside a rock 3Understanding faults and volcanics, plus life inside a rock 4Understanding faults and volcanics, plus life inside a rock 5Understanding faults and volcanics, plus life inside a rock 6Understanding faults and volcanics, plus life inside a rock 7Understanding faults and volcanics, plus life inside a rock 8Understanding faults and volcanics, plus life inside a rock 9
...
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Biology Products: